Development Of Cardiovascular Plaque Blaster
School Name
Center for Advanced Technical Studies
Grade Level
12th Grade
Presentation Topic
Biochemistry
Presentation Type
Non-Mentored
Abstract
The mission of this engineering innovation is to reduce the amount of Atherosclerosis in CAD by breaking it down faster where it can flush out the body. With the liquid Blaster, it will benefit patients who have rapid increase and substantial plaque build-up, the top targeted patients would be, anyone the Ages 65+, Postmenopausal women, and Obese Individuals. It is of great importance to treat CAD because if left untreated the condition can lead to other Heart issues such as Cardiogenic shock which can lead to a severe heart attack that can cause death. Heart Diseases such as CAD are the number 1 leading Cause of death in the U.S said the CDC due to the fact heart disease that causes atherosclerosis can vary and morph into serval types of other heart conditions. With the liquid supplement, the goal or main purpose is to just slow down how much plaque is building and to break down larger portions the study of this innovation will be different from other products already out due to its liquid base quality and ingredients used for the artery as well for the fact the plaque was hand made and dried vs finding a heart to actually test on. The natural selection with a portion of acids and enzymes method was chosen to keep the nonartificial aspect of the liquid and to have an effective breakdown process in the artery in the research process results found that products like sunflower oil any natural plant product, seeds etc help plaque break down. the innovation will see results when over the course of 3-5 trials, less and less atherosclerosis shows up in the tube that is used to represent the artery. This innovation is not to cure the disease but to lessen the chances of risk increases.
Recommended Citation
Jenkins, Asah, "Development Of Cardiovascular Plaque Blaster" (2022). South Carolina Junior Academy of Science. 166.
https://scholarexchange.furman.edu/scjas/2022/all/166
Location
HSS 206
Start Date
4-2-2022 10:00 AM
Presentation Format
Oral Only
Group Project
No
Development Of Cardiovascular Plaque Blaster
HSS 206
The mission of this engineering innovation is to reduce the amount of Atherosclerosis in CAD by breaking it down faster where it can flush out the body. With the liquid Blaster, it will benefit patients who have rapid increase and substantial plaque build-up, the top targeted patients would be, anyone the Ages 65+, Postmenopausal women, and Obese Individuals. It is of great importance to treat CAD because if left untreated the condition can lead to other Heart issues such as Cardiogenic shock which can lead to a severe heart attack that can cause death. Heart Diseases such as CAD are the number 1 leading Cause of death in the U.S said the CDC due to the fact heart disease that causes atherosclerosis can vary and morph into serval types of other heart conditions. With the liquid supplement, the goal or main purpose is to just slow down how much plaque is building and to break down larger portions the study of this innovation will be different from other products already out due to its liquid base quality and ingredients used for the artery as well for the fact the plaque was hand made and dried vs finding a heart to actually test on. The natural selection with a portion of acids and enzymes method was chosen to keep the nonartificial aspect of the liquid and to have an effective breakdown process in the artery in the research process results found that products like sunflower oil any natural plant product, seeds etc help plaque break down. the innovation will see results when over the course of 3-5 trials, less and less atherosclerosis shows up in the tube that is used to represent the artery. This innovation is not to cure the disease but to lessen the chances of risk increases.